FTC Staff Issues FY 2017 Report on Branded Drug Firms’ Patent Settlements with Generic Competitors
WASHINGTON, D.C. — According to a new FTC staff report, the total number of final Hatch-Waxman patent settlements entered by pharmaceutical companies in FY 2017 was close to the record high …
Read More